Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Alopecia × efalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Alopecia 1

Interventions

Surveys and Questionnaires 3 CG428 2 proxalutamide 1 efalizumab 1 Yoga 1 Standard of Care 1 Norepinephrine 1 Minoxidil 1 Low-Level Light Therapy 1 Immunoconjugates 1 Doxorubicin 1 Docetaxel 1 Cyproterone Acetate 1 Cyclophosphamide 1 Cryotherapy 1 Coconut Oil 1 Calcitriol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00746980 2016-06-14

Efalizumab in the Treatment of Alopecia, Phase II

Northwestern University

Phase 2 Withdrawn

Alopecia, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡